A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
Explore related content and topics
Case Study
Overcoming Recruitment Challenges to Meet Vaccine Study Enrollment
Through an enhanced enrollment plan, PRA helped a client meet challenging enrollment goals in a vaccine study. Our innovative strategies contributed…
View Resource
Case Study
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…
View Resource
Case Study
PRA Exceeds Tough Enrollment Goals
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in…
View Resource
View all related content and resources for Site Identification and Selection
Explore Insights